Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection. | JCI Insight | 2025 | 40168094 | PubTator, text mining | PubMed |
| Bradykinin's carbamylation as a mechanistic link to impaired wound healing in patients with kidney dysfunction. | BMC Biol | 2025 | 40075424 | PubTator, text mining | PubMed |
| Deletion of kinin receptor B2 enhances orthodontic tooth movement and alveolar bone remodeling. | PLoS One | 2025 | 40019931 | PubTator, text mining | PubMed |
| Dextran sodium sulfate-induced colitis in male BALB/c mice leads to albuminuria and increased markers of inflammation and tissue damage in the kidney. | Physiol Rep | 2025 | 40018982 | PubTator, text mining | PubMed |
| Bradykinin B1 receptor signaling triggers complement activation on endothelial cells. | Front Immunol | 2025 | 39991158 | PubTator, text mining | PubMed |
| Identification of inflammation-related genes signature to establish a prognostic model in MGMT unmethylated glioblastoma patients. | Discov Oncol | 2025 | 39932605 | PubTator, text mining | PubMed |
| Analysis of serum concentrations of metoprolol and its metabolite α-hydroxymetoprolol in patients with heart failure with reduced ejection fraction: a pilot study in routine health care. | Expert Rev Clin Pharmacol | 2025 | 39757778 | PubTator, text mining | PubMed |
| Sympathetic nerve activity and response to physiological stress in Takotsubo syndrome. | Clin Auton Res | 2025 | 39546154 | PubTator, text mining | PubMed |
| Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma Fibrosis. | Arthritis Rheumatol | 2025 | 39175116 | PubTator, text mining | PubMed |
| Novel Insights into the Kallikrein-Kinin System in Fulminant Myocarditis: Physiological Basis and Potential Therapeutic Advances. | J Inflamm Res | 2024 | 39429854 | PubTator, text mining | PubMed |
| The dynamics and behavior of logarithmic type fuzzy difference equation of order two. | PLoS One | 2024 | 39423196 | PubTator, text mining | PubMed |
| Involvement of the Kinin B1 Receptor in Increased Permeability of Cerebral Microvessels in Rats Subjected to Autoimmune Encephalomyelitis. | Cells | 2024 | 39404404 | PubTator, text mining | PubMed |
| Tissue Kallikrein supplementation in ischemic phase protects the neurovascular unit and attenuates reperfusion-induced injury in ischemic stroke. | Pharmacol Res | 2024 | 39349214 | PubTator, text mining | PubMed |
| Generation of rabbit single-chain variable fragments with different physicochemical and biological properties by complementary determining region-grafting technology. | J Biosci Bioeng | 2024 | 39198103 | PubTator, text mining | PubMed |
| Mechanisms of the septic heart: From inflammatory response to myocardial edema. | J Mol Cell Cardiol | 2024 | 39142438 | PubTator, text mining | PubMed |
| Assessment of Radiolabelled Derivatives of R954 for Detection of Bradykinin B1 Receptor in Cancer Cells: Studies on Glioblastoma Xenografts in Mice. | Pharmaceuticals (Basel) | 2024 | 39065752 | PubTator, text mining | PubMed |
| "Radical" differences between two FLIM microscopes affect interpretation of cell signaling dynamics. | iScience | 2024 | 39036041 | PubTator, text mining | PubMed |
| Kinin B1 receptor deficiency promotes enhanced adipose tissue thermogenic response to β3-adrenergic stimulation. | Inflamm Res | 2024 | 39017739 | PubTator, text mining | PubMed |
| Inotropic Agents: Are We Still in the Middle of Nowhere? | J Clin Med | 2024 | 38999301 | PubTator, text mining | PubMed |
| Kinin B1 receptor and TLR4 interaction in inflammatory response. | Inflamm Res | 2024 | 38965133 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=3